David Dornan
Chief Tech/Sci/R&D Officer at ELEVATION ONCOLOGY, INC.
Net worth: - $ as of 2024-03-30
Profile
David Dornan is currently the Chief Scientific Officer at Elevation Oncology, Inc. Prior to this, he was the Senior Vice President of Research & Manufacturing at Bolt Biotherapeutics, Inc. from 2019 to 2022.
From 2012 to 2017, he worked at Gilead Sciences, Inc. as the Director & Head of Oncology Research.
Dr. Dornan holds a doctorate degree from the University of Dundee and an undergraduate degree from the University of Strathclyde.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
-.--% | 2024-02-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
David Dornan active positions
| Companies | Position | Start |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2022-03-13 |
Former positions of David Dornan
| Companies | Position | End |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-03-10 |
| GILEAD SCIENCES, INC. | Director/Board Member | 2017-10-31 |
Training of David Dornan
| University Of Dundee | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
- Stock Market
- Insiders
- David Dornan